Please login to the form below

Not currently logged in
Email:
Password:

Idis

This page shows the latest Idis news and features for those working in and with pharma, biotech and healthcare.

Quantum Pharma confirms Clinigen takeover bid

Quantum Pharma confirms Clinigen takeover bid

In 2015 it bought Idis for £225m to gain a firmer foothold in the $5bn unlicensed medicines market and in clinical trial supply.

Latest news

  • Clinigen acquires Idis for £225m Clinigen acquires Idis for £225m

    Clinigen acquires Idis for £225m. Acquisition makes them the global leader in unlicensed medicines. ... Idis supplies unlicensed medicines predominantly on an exclusive basis through managed access programmes as well as on demand via its general access

  • Langland triumphs at IPA Best of Health Awards Langland triumphs at IPA Best of Health Awards

    Langland triumphs at IPA Best of Health Awards. Windsor, UK agency wins Best of Show for Idis campaign. ... year at the IPA event, where its campaign for Idis swept the board.

  • Langland steals the pharma show at first Lions Health Langland steals the pharma show at first Lions Health

    four silver prizes for its work for Idis.

  • VCCP Health takes lead at PM Society Awards VCCP Health takes lead at PM Society Awards

    There were prizes for work for AbbVie and IDIS for Langland; Becton, Dickinson &Company and AstraZeneca for Saatchi &Saatchi Health; and Teva Europe and Napp for Woolley Pau Gyro. ... Crestor for AstraZeneca by Saatchi &Saatchi Health (Joint Winner). I

  • Langland leads Global Award winners Langland leads Global Award winners

    A major integrated campaign by Langland also won the Grand Global award in the Professional Healthcare category for its work for Idis. ... And winning the Grand Global for our work for Idis is a real honour,” said Langland chief executive Philip Chin.

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Former Quintiles president Jeff Thomis to chair Idis Former Quintiles president Jeff Thomis to chair Idis

    Former Quintiles president Jeff Thomis to chair Idis. Will oversee company’ s activities to develop managed access programmes for medicines. ... Idis has appointed Jeff Thomis as chairman to oversee the company's activities in creating managed access

  • Suzanne Gagnon joins Idis as CMO Suzanne Gagnon joins Idis as CMO

    Suzanne Gagnon joins Idis as CMO. She was formerly chief medical officer at Icon. ... Dr Gagnon will lead global medical affairs at Idis, which specialises in partnering with pharma firms to support patient access to medicines.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics